NCT04865120 is a NA clinical trial of cream cyclic merocyanine in Sunscreen Sensitivity, sponsored by L'Oreal.

Who is sponsoring NCT04865120?

NCT04865120 is sponsored by L'Oreal.

What drugs are being tested in NCT04865120?

Interventions in NCT04865120: cream cyclic merocyanine, placebo.

What condition does NCT04865120 study?

NCT04865120 studies Sunscreen Sensitivity, Ultraviolet-Induced Change in Normal Skin.

Is NCT04865120 still recruiting?

NCT04865120 is currently status unknown. Last updated 29 April 2021.

Last reviewed 2021-04-29 · How we verify

NCT04865120

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Photoprotection Efficacy With Sunscreen Formulas Containing the Cyclic Merocyanine Long-UVA Absorber MCE Under Long-UVA Exposure.

Status unknown NA Last updated 29 April 2021

What this trial tests

NA trial testing cream cyclic merocyanine in Sunscreen Sensitivity in 50 participants. Status unknown.

Timeline

29 April 2021

Primary endpoint
10 June 2021

10 June 2021

Quick facts

Lead sponsor	L'Oreal
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	quadruple
Primary purpose	treatment
Enrollment	50
Start date	29 April 2021
Primary completion	10 June 2021
Estimated completion	10 June 2021
Sites	1 location across Romania

Drugs / interventions tested

cream cyclic merocyanine
placebo

Conditions studied

Sunscreen Sensitivity — all drugs for Sunscreen Sensitivity →
Ultraviolet-Induced Change in Normal Skin — all drugs for Ultraviolet-Induced Change in Normal Skin →

Sponsor

L'Oreal — full company profile →

Who can join

Adults 18 to 40, any sex, with Sunscreen Sensitivity or Ultraviolet-Induced Change in Normal Skin. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the photo-protector effect of BC\_3 (E212657) formulated in SPF compared to SPF alone on long-UVA induced pigmentation in healthy volunteers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other L'Oreal trials

Trials by the same sponsor.

NCT06813521 — Antidandruff Lotion Mediating Microbiome Rebalance · NA · recruiting
NCT06066463 — My Skin & Hair Journey_virtual Registry · suspended
NCT06937515 — MELASYL EFFICACY UNDER PART OF VISIBLE LIGHT · completed
NCT07462845 — Agents Effect Under Visible Light on Caucasian, Asian and Darker Skin Types · completed
NCT05502185 — Targeting Staphylococci in Atopic Dermatitis · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04865120 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by L'Oreal
Last refreshed: 29 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04865120.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing